Research Grants
Funding For:
The Rise of Compounded GLP-1 Weight Loss Medications: A Landscape Analysis of the Direct-To-Consumer Market
Health Care Management / Cost & Quality / Prescription Drugs
Recipient:
Michael DiStefano, University of Colorado
Grant Period:
Jan 01, 2025 - Dec 31, 2025
AMOUNT:
$46,967.00
Summary of the Project:
During GLP-1 shortages, compounded versions of the drugs gained popularity as a cheaper alternative to sought after weight loss drugs. This study will look at the rise in compounded GLP-1 products advertised and sold to consumers by telehealth platforms, weight loss clinics, and medical spas. It will identify and describe the direct-to-consumer market for these products in the US, including advertising claims regarding the safety and efficacy of compounded GLP-1 products.